CannaPharmaRx, Inc. Opens Headquarters in New Jersey

CannaPharmaRx, Inc., (OTC: GDHC), a pharmaceutical company whose mission is to advance cannabinoid discovery, science, research & development, and to bring novel prescription, veterinary and personal care cannabinoid-based products to market in the U.S. and worldwide, announced today that that they officially have taken possession of their new headquarters in Carney’s Point Township, New Jersey.

Establishing our headquarters in New Jersey puts us in close proximity to some of the most experienced pharmaceutical executives in the world. Not only is it a rich source of human capital, it is ideally geographically positioned for easy access to our staff and development partners.

said Gerry Crocker, CannaPharmaRx CEO.

For more information, visit their Public Profile on or their website.

Source PRWeb

Leave a Reply

Your email address will not be published. Required fields are marked *